AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Drax Group PLC

Transaction in Own Shares Jan 7, 2019

4844_rns_2019-01-07_7ae419d0-5403-4146-86c0-53f819f383cb.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4284M

Drax Group PLC

07 January 2019

Transactions in own shares

Drax Group plc (the Company) announces today it has purchased the following number of its ordinary shares of 11 16/29 pence each through J.P. Morgan Securities plc.

Date of purchase: 7 January 2019
Aggregate number of ordinary shares purchased: 3,803
Lowest price paid per share: 364.40000
Highest price paid per share: 367.00000
Average price paid per share: 366.15293

The Company intends to hold the purchased shares in treasury.

Since 20 April 2018, the Company has purchased 13,458,844 shares at a cost (including dealing and associated costs) of £48,720,974.24.

Following the above transaction, the Company holds 13,458,844, of its ordinary shares in treasury and has 393,734,324 ordinary shares in issue (excluding treasury shares).

The table below contains detailed information about the purchases made as part of the buyback programme.

Schedule of Purchases

Shares purchased: 3,803 (ISIN: GB00B1VNSX38)
Date of purchases: 7 January 2019
Investment firm: J.P. Morgan Securities plc

Aggregate information:

Venue Volume-weighted average price (GBp) Aggregated volume Lowest price per share (GBp) Highest price per share (GBp)
London Stock Exchange 366.15293 3,803 364.40000 367.00000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

POSEAXFXEEKNEFF

Talk to a Data Expert

Have a question? We'll get back to you promptly.